CoChat

Anti‐Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity

Open access
Chai, Louis Y. A., Van De Veerdonk, Frank, Marijnissen, Renoud J., Cheng, Shih‐Chin, Khoo, Ai Leng, Hectors, Magda, Lagrou, Katrien, Vonk, Alieke G., Maertens, Johan, Joosten, Leo A. B., Kullberg, Bart‐Jan, Netea, Mihai G. · 2010 · Immunology
Cited by 127

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Summary: Both interferon‐γ‐producing type 1 T helper (Th1)‐ and interleukin‐17 (IL‐17)‐producing Th17 cells have been proposed to be involved in anti‐fungal host defence. Although invasive aspergillosis is one of the most severe human fungal infections, little is known regarding the relative importance of the Th1 versus Th17 cellular immune pathways for the human anti‐Aspergillus host defence. Using human peripheral blood mononuclear cells and a system consisting of monocyte‐derived macrophages with lymphocytes, we found that Aspergillus fumigatus is a weak inducer of human IL‐17 but induces a strong Th1 response. These data were validated by the very low IL‐17 levels in bronchoalveolar lavage fluid and serum of patients with invasive aspergillosis. Surprisingly, live A. fumigatus reduced IL‐17 production induced by mitogenic stimuli. This effect was mediated through the propensity of A. fumigatus to metabolize tryptophan and release kynurenine, which modulates the inflammatory response through inhibition of IL‐17 production. In conclusion, A. fumigatus does not stimulate production of IL‐17 and human host defence against aspergillosis may not rely on potent Th17 responses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2567.2009.03211.x

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 127

Metadata

Authors
Chai, L. Y. A., Van De Veerdonk, F., Marijnissen, R. J., Cheng, S., Khoo, A. L., Hectors, M., Lagrou, K., Vonk, A. G., Maertens, J., Joosten, L. A. B., Kullberg, B., & Netea, M. G.
Venue
Immunology
Publisher
Wiley
Published
2010-04-06
Volume
130
Issue
1
Pages
46-54
ISSN
  • 0019-2805 (ISSN-L)
  • 1365-2567
OpenAlex
W2107002415
Cited by
127
References
16
FWCI
5.86
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Anti‐Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. https://app.cochat.ai/papers/10.1111/j.1365-2567.2009.03211.x
The paper
Chai, L. Y. A., Van De Veerdonk, F., Marijnissen, R. J., Cheng, S., Khoo, A. L., Hectors, M., Lagrou, K., Vonk, A. G., Maertens, J., Joosten, L. A. B., Kullberg, B., & Netea, M. G. (2010). Anti‐Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity. Immunology. https://doi.org/10.1111/j.1365-2567.2009.03211.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.